HutchingsJWinklerJLFullerTSWhen the morning after is Sunday: pharmacist prescribing of emergency contraceptive pills. J Am Med Womens Assoc1998;53(5Suppl 2):230–2.
2.
Task Force on Pharmacist Prescribing (Pearson G, Yuksel N, Card D, et al.). Statement on pharmacist prescribing. Can J Hosp Pharm2002;55:55.
3.
Task Force on Pharmacist Prescribing (Pearson G, Yuksel N, Card D, et al.). An information paper on pharmacist prescribing within a health care facility. Can J Hosp Pharm2002;55:56–62.
4.
HolzmannT. Pharmacist prescribing no threat to physicians. Can Pharm J2003;136(2):11, 47.
5.
RoweT. The Canadian Consensus Conference on Contraception. J Soc Obstet Gynaecol Can1998;20(7):667–92.
6.
WesthoffC. Emergency contraception. N Engl J Med2003;349:1830–5.
7.
GrimesDRaymondEG. Emergency contraception. Ann Intern Med2002;137:180–9.
8.
Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet1998;352:428–33.
9.
SoonJALevineMEnsomMHHThe developing role of pharmacists in patient access to emergency contraception. Dis Manage Health Outcomes2002;10:601–11.
10.
WellsESHutchingsJGardnerJSUsing pharmacies in Washington State to expand access to emergency contraception. Fam Plann Perspect1998;30:288–90.
11.
von HertzenHPiaggioGDingJWorld Health Organization Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet2002;360:1803–10.
12.
RodriguesIGrouFJolyJ. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol2001;184:531–7.
13.
EllertsonCWebbABlanchardKModifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet Gynecol2003;101:1160–7.
14.
The Society of Obstetricians and Gynaecologists of Canada. Motion on emergency postcoital contraception. Council Meeting, November 14&15, 1998. Motion-14&15 Nov 98-COU 31. Ottawa, ON.
15.
YuzpeAAThurlowHJRamzyILeyshonJI. Postcoital contraception—a pilot study. J Reprod Med1974;13:53–8.
16.
British Columbia Vital Statistics Agency. Pregnancy counts and rates by age groups by health region: British Columbia 1990/1991 to 1998/1999. Victoria: The Agency; 1999:124.
17.
Washington State Pharmacy Association. Washington State Pharmacy Association Emergency Contraception Training Manual. Renton, WA; 1999.
18.
GardnerJSHutchingsJFullerTSDowningD. Increasing access to emergency contraception through community pharmacists: lessons from Washington State. Fam Plann Perspect2001;33:172–5.
19.
SoonJALevineMOsmondBLEnsomMHHFieldingDW. Pharmacist-initiated emergency contraceptives in British Columbia: expanded access enhances patient choice. Can Pharm J2003;136:6:49.
Therapeutic Products Directorate. Factors for listing drugs in Schedule F. Ottawa: Health Canada; 1989 Dec 6 (reposted 1999 Aug 9). Available: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/listschf_e.html (accessed June 29, 2004).
DunnSBrownTECohenMMPharmacy provision of emergency contraception: the Ontario emergency contraception pilot project. J Obstet Gynaecol Can2003;25:923–30.
Therapeutic Products Directorate. Amendment to the Food and Drug Regulations — Schedule 1272 (deletion of levonorgestrel, when indicated for use as an emergency contraceptive, from Schedule F of the Food and Drug Regulations). Request for stakeholder comments. Ottawa: Health Canada; June 16, 2003. Available: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/sch-1272_e.html (accessed June 29, 2004).
27.
Harrison-WoolrychMHoweJSmithC. Improving access to emergency contraception [editorial]. BMJ2001;322:186–7.